COVID-19 Among Patients With Multiple Sclerosis: A Systematic Review

Conclusion
Our study suggested that MS did not significantly increase the mortality rate from COVID-19. These data should be interpreted with caution as patients with MS are more likely female and younger compared with the general population where age and male sex seem to be risk factors for worse disease outcome.

Source: Neurology Neuroimmunology and Neuroinflammation - May 20, 2021 Category: Neurology Authors: Barzegar, M., Mirmosayyeb, O., Gajarzadeh, M., Afshari-Safavi, A., Nehzat, N., Vaheb, S., Shaygannejad, V., Maghzi, A.-H. Tags: COVID-19, Multiple sclerosis Views [amp ] Reviews Source Type: research